Advanced

Relapse of Endometrial Carcinoma: Follow-up of 272 Patients with Relapse.

Lindahl, Bengt LU ; Ranstam, Jonas LU and Willén, Roger (2012) In Anticancer Research 32(8). p.3391-3395
Abstract
A total of 2090 patients with endometrial carcinoma were followed-up for at least five years. The treatment modalities, as well as the results of treatment, regarding 272 patients with disease relapse are presented. The results are not encouraging. We found no statistically significant difference regarding overall survival, when the patients were divided according to initial stage or ploidy status. There was also no significant difference between overall survival and the mode of treatment. 108 out of 272 patients with relapse died of their disease. Regarding patients in stage I-II we present the survival for every studied year, where we compared those with more than one site of metastasis (n=108), more than one metastasis (n=59), or no... (More)
A total of 2090 patients with endometrial carcinoma were followed-up for at least five years. The treatment modalities, as well as the results of treatment, regarding 272 patients with disease relapse are presented. The results are not encouraging. We found no statistically significant difference regarding overall survival, when the patients were divided according to initial stage or ploidy status. There was also no significant difference between overall survival and the mode of treatment. 108 out of 272 patients with relapse died of their disease. Regarding patients in stage I-II we present the survival for every studied year, where we compared those with more than one site of metastasis (n=108), more than one metastasis (n=59), or no relapse at all (n=1289) with an age-corrected Swedish female population. We found that the vast majority of patients did not die from their cancer-related illnesses, and also found an increased death-rate among those with cancer without relapse, compared to those without cancer (20% compared to 14%, 5 year follow-up). We conclude that the majority of patients would benefit from an increased effort to cure other illnesses rather than concentrating on cancer treatment alone. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Anticancer Research
volume
32
issue
8
pages
3391 - 3395
publisher
International Institute of Cancer Research
external identifiers
  • wos:000306892700052
  • pmid:22843920
  • scopus:84865676051
ISSN
1791-7530
language
English
LU publication?
yes
id
ae5a0200-08a3-405c-8944-16089941ee34 (old id 2966408)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/22843920?dopt=Abstract
date added to LUP
2012-08-10 09:36:03
date last changed
2017-01-01 07:37:23
@article{ae5a0200-08a3-405c-8944-16089941ee34,
  abstract     = {A total of 2090 patients with endometrial carcinoma were followed-up for at least five years. The treatment modalities, as well as the results of treatment, regarding 272 patients with disease relapse are presented. The results are not encouraging. We found no statistically significant difference regarding overall survival, when the patients were divided according to initial stage or ploidy status. There was also no significant difference between overall survival and the mode of treatment. 108 out of 272 patients with relapse died of their disease. Regarding patients in stage I-II we present the survival for every studied year, where we compared those with more than one site of metastasis (n=108), more than one metastasis (n=59), or no relapse at all (n=1289) with an age-corrected Swedish female population. We found that the vast majority of patients did not die from their cancer-related illnesses, and also found an increased death-rate among those with cancer without relapse, compared to those without cancer (20% compared to 14%, 5 year follow-up). We conclude that the majority of patients would benefit from an increased effort to cure other illnesses rather than concentrating on cancer treatment alone.},
  author       = {Lindahl, Bengt and Ranstam, Jonas and Willén, Roger},
  issn         = {1791-7530},
  language     = {eng},
  number       = {8},
  pages        = {3391--3395},
  publisher    = {International Institute of Cancer Research},
  series       = {Anticancer Research},
  title        = {Relapse of Endometrial Carcinoma: Follow-up of 272 Patients with Relapse.},
  volume       = {32},
  year         = {2012},
}